Device Inspection Survey Shows FDA Consistency, Image Improvement
This article was originally published in The Gray Sheet
Executive Summary
FDA inspections of medical device companies are consistent across different Office of Regulatory Affairs district offices, according to a survey organized by the Medical Device Industry Initiative Grassroots Taskforce.
You may also be interested in...
BIMO Routine Inspections Will Be Pre-Announced
CDRH's bioresearch monitoring division (BIMO) has started pre-announcing routine audits. Under the new policy, the inspections are being announced about five days beforehand
BIMO Routine Inspections Will Be Pre-Announced
CDRH's bioresearch monitoring division (BIMO) has started pre-announcing routine audits. Under the new policy, the inspections are being announced about five days beforehand
FDA'S PILOT INSPECTION PROGRAM TO BECOME PERMANENT, AGENCY'S CHESEMORE TELLS HIMA; EIRs WILL AUTOMATICALLY BE ISSUED TO MANUFACTURERS BEGINNING IN APRIL
FDA's pilot pre-announced inspection program for device manufacturers is being made permanent, Ronald Chesemore, the agency's associate commissioner for regulatory affairs, told attendees at the Health Industry Manufacturers Association annual meeting March 16 in St. Petersburg, Florida. Encouraged by favorable feedback from FDA inspectors and industry, the agency has decided to implement the initiative as a "permanent change in our medical device program," Chesemore said.